Faes Farma, officially known as Faes Farma S.A., is a prominent pharmaceutical company headquartered in Spain. Established in 1933, the company has evolved into a key player in the healthcare industry, focusing on the development, manufacturing, and marketing of innovative pharmaceutical products. With a strong presence in Europe and Latin America, Faes Farma is dedicated to therapeutic areas such as central nervous system disorders, respiratory diseases, and dermatology. The company is recognised for its unique formulations and commitment to research and development, which have led to several notable achievements in the pharmaceutical sector. Faes Farma's extensive portfolio includes both prescription medications and over-the-counter products, positioning it as a trusted name in the market. With a rich history and a forward-thinking approach, Faes Farma continues to make significant contributions to global health.
How does Faes Farma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Faes Farma's score of 27 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Faes Farma reported total carbon emissions of approximately 7,280,000 kg CO2e, comprising 4,965,000 kg CO2e from Scope 1 and 2,615,000 kg CO2e from Scope 2 emissions. This reflects a notable increase from 2022, where emissions were about 4,268,000 kg CO2e, with 3,782,000 kg CO2e from Scope 1 and 856,000 kg CO2e from Scope 2. In 2021, the company recorded emissions of approximately 5,054,000 kg CO2e, with 3,874,000 kg CO2e from Scope 1 and 1,652,000 kg CO2e from Scope 2. Faes Farma has not disclosed any specific reduction targets or initiatives as part of its climate commitments. The company does not currently report Scope 3 emissions, which encompass indirect emissions in the value chain. Furthermore, there are no climate pledges or SBTi (Science Based Targets initiative) commitments noted in the available data. The emissions data is sourced directly from Faes Farma, S.A., and there is no indication of data being cascaded from a parent or related organization. The company continues to monitor its carbon footprint as part of its operational strategy.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | |
---|---|---|---|
Scope 1 | 3,874,000 | 0,000,000 | 0,000,000 |
Scope 2 | 1,652,000 | 000,000 | 0,000,000 |
Scope 3 | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Faes Farma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.